000 | 01957 a2200565 4500 | ||
---|---|---|---|
005 | 20250513204629.0 | ||
264 | 0 | _c20000331 | |
008 | 200003s 0 0 eng d | ||
022 | _a0002-9149 | ||
024 | 7 |
_a10.1016/s0002-9149(99)00768-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMadan, M | |
245 | 0 | 0 |
_aEfficacy of abciximab readministration in coronary intervention. _h[electronic resource] |
260 |
_bThe American journal of cardiology _cFeb 2000 |
||
300 |
_a435-40 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aAbciximab |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aCoronary Angiography |
650 | 0 | 4 |
_aCoronary Disease _xdiagnostic imaging |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xadministration & dosage |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aIntracranial Hemorrhages _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMyocardial Revascularization |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
650 | 0 | 4 | _aPostoperative Period |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSafety |
650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aKereiakes, D J | |
700 | 1 | _aHermiller, J B | |
700 | 1 | _aRund, M M | |
700 | 1 | _aTudor, G | |
700 | 1 | _aAnderson, L | |
700 | 1 | _aMcDonald, M B | |
700 | 1 | _aBerkowitz, S D | |
700 | 1 | _aSketch, M H | |
700 | 1 | _aPhillips, H R | |
700 | 1 | _aTcheng, J E | |
773 | 0 |
_tThe American journal of cardiology _gvol. 85 _gno. 4 _gp. 435-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9149(99)00768-7 _zAvailable from publisher's website |
999 |
_c10682696 _d10682696 |